{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:35:46Z","timestamp":1793086546835,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Borderline breast lesions (B3 lesions, also termed lesions of uncertain malignant potential or high-risk lesions) represent a heterogeneous group of entities associated with variable risks of malignancy. While the management of screen-detected B3 lesions has become increasingly standardised, no dedicated international recommendations exist for symptomatic B3 lesions, despite them posing a distinct clinical challenge. Symptomatic lesions differ from screen-detected lesions in their mode of presentation, lesion characteristics, biopsy techniques, and diagnostic objectives; consequently, management strategies derived from screening populations may not be directly applicable. This review summarises the current evidence and proposes a pragmatic management framework for B3 lesions encountered in the symptomatic setting (defined as those presenting with breast symptoms outside population-based screening programmes). This is particularly relevant for patients under 50 years of age, where the primary objective is to exclude malignancy at the index site rather than solely to stratify long-term cancer risk. Clinical-radiological-pathological concordance and multidisciplinary assessment are central to management decisions. Lesions presenting as palpable abnormalities (which are typically larger) or those demonstrating radiological-pathological discordance warrant a lower threshold for additional sampling or excision. Conversely, selected concordant lesions without atypia may be managed conservatively following adequate sampling. The long-term cancer risk associated with epithelial atypia should also be considered with subsequent risk-based surveillance implemented where appropriate. Overall, management requires a risk-adapted, multidisciplinary approach integrating pathological, radiological, and clinical factors alongside patient symptoms and quality-of-life considerations. Given the limited evidence, current recommendations rely on expert consensus and a proposed practical framework. They underscore the need for large-scale, high-quality studies with long-term follow-up to establish formal clinical guidelines.<\/jats:p>","DOI":"10.1007\/s00428-026-04672-2","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:53:33Z","timestamp":1786334013000},"page":"783-796","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of high-risk (B3) breast lesions in symptomatic practice: evidence review and practical recommendations for multidisciplinary care"],"prefix":"10.1007","volume":"489","author":[{"given":"Emad A.","family":"Rakha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Floris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Callagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavan","family":"Vidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Regitnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Masannat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill R.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Altrabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna A.","family":"Abuhejleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"van Diest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Cserni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Foschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien H.M.","family":"van Deurzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Charafe-Jauffret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha El","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Bago-Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Grobmyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke R.","family":"Van Bockstal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puay Hoon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecily","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the UK National Coordinating Committee for Breast Pathology and the European Working Group for Breast Screening Pathology","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"4672_CR1","volume-title":"Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening","author":"AHS Lee","year":"2016","unstructured":"Lee AHS, Carder P, Deb R (June2016) Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. The Royal College of Pathologists, London"},{"key":"4672_CR2","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/jcp.2006.045377","volume":"60","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, Ellis IO (2007) An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J Clin Pathol 60:1300\u20131306","journal-title":"J Clin Pathol"},{"key":"4672_CR3","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.ejca.2008.05.024","volume":"44","author":"ME El-Sayed","year":"2008","unstructured":"El-Sayed ME, Rakha EA, Reed J et al (2008) Audit of performance of needle core biopsy diagnoses of screen detected breast lesions. Eur J Cancer 44:2580\u20132586","journal-title":"Eur J Cancer"},{"key":"4672_CR4","doi-asserted-by":"publisher","first-page":"100734","DOI":"10.1016\/j.modpat.2025.100734","volume":"38","author":"EA Rakha","year":"2025","unstructured":"Rakha EA, Quinn C, Raymond W et al (2025) Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management. Mod Pathol 38:100734","journal-title":"Mod Pathol"},{"key":"4672_CR5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s11845-018-1781-6","volume":"187","author":"XC Huang","year":"2018","unstructured":"Huang XC, Hu XH, Wang XR et al (2018) A comparison of diagnostic performance of vacuum-assisted biopsy and core needle biopsy for breast microcalcification: a systematic review and meta-analysis. Ir J Med Sci 187:999\u20131008","journal-title":"Ir J Med Sci"},{"key":"4672_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-025-12299-1","author":"N Sharma","year":"2026","unstructured":"Sharma N, Theis S, Vogelmann T et al (2026) Vacuum-assisted breast biopsy vs core needle biopsy: a systematic review and meta-analysis. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-025-12299-1","journal-title":"Eur Radiol"},{"key":"4672_CR7","unstructured":"American Society of Breast Surgeons\u00a0(2016) Consensus guideline on concordance assessment of image-guided breast biopsies and management of borderline or high-risk lesions. Available from: https:\/\/associationofbreastsurgery.org.uk\/media\/0naeglap\/asbs-concordance_and_high-risk-lesions.pdf. Accessed Feb 2026"},{"key":"4672_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.path.2025.05.001","volume":"18","author":"A Grabenstetter","year":"2025","unstructured":"Grabenstetter A (2025) High-Risk Breast Lesions on Core Biopsy: Rates of Upgrade and Management Recommendations. Surg Pathol Clin 18:707\u2013723","journal-title":"Surg Pathol Clin"},{"key":"4672_CR9","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1148\/radiol.2017170549","volume":"286","author":"M Bahl","year":"2018","unstructured":"Bahl M, Barzilay R, Yedidia AB et al (2018) High-Risk Breast Lesions: A Machine Learning Model to Predict Pathologic Upgrade and Reduce Unnecessary Surgical Excision. Radiology 286:810\u2013818","journal-title":"Radiology"},{"key":"4672_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.107292","volume":"50","author":"IT Rubio","year":"2024","unstructured":"Rubio IT, Wyld L, Marotti L et al (2024) European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO. Eur J Surg Oncol 50:107292","journal-title":"Eur J Surg Oncol"},{"key":"4672_CR11","unstructured":"National Coordinating Group for Breast Screening Pathology (1997) Guidelines for cytology and histology in breast cancer screening, vol 49. NHSBSP Publication No"},{"key":"4672_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s004280050297","volume":"434","author":"JP Sloane","year":"1999","unstructured":"Sloane JP, Amendoeira I, Apostolikas N et al (1999) Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology. Virchows Arch 434:3\u201310","journal-title":"Virchows Arch"},{"key":"4672_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jcp.2003.010983","volume":"57","author":"IO Ellis","year":"2004","unstructured":"Ellis IO, Humphreys S, Michell M et al (2004) Best Practice 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clin Pathol 57:897\u2013902","journal-title":"J Clin Pathol"},{"key":"4672_CR14","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1016\/j.clbc.2023.03.006","volume":"23","author":"N Willers","year":"2023","unstructured":"Willers N, Neven P, Floris G et al (2023) The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study. Clin Breast Cancer 23:e273\u2013e280","journal-title":"Clin Breast Cancer"},{"key":"4672_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00428-023-03566-x","volume":"483","author":"C Elfgen","year":"2023","unstructured":"Elfgen C, Leo C, Kubik-Huch RA et al (2023) Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Virchows Arch 483:5\u201320","journal-title":"Virchows Arch"},{"key":"4672_CR16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.crad.2018.04.004","volume":"73","author":"SE Pinder","year":"2018","unstructured":"Pinder SE, Shaaban A, Deb R et al (2018) NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions). Clin Radiol 73:682\u2013692","journal-title":"Clin Radiol"},{"key":"4672_CR17","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20211326","volume":"96","author":"MS Guirguis","year":"2023","unstructured":"Guirguis MS, Yang WT (2023) Overview of incidental breast lesions. Br J Radiol 96:20211326","journal-title":"Br J Radiol"},{"key":"4672_CR18","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.ejso.2022.04.005","volume":"48","author":"C Cullinane","year":"2022","unstructured":"Cullinane C, Byrne J, Kelly L et al (2022) The positive predictive value of vacuum assisted biopsy (VAB) in predicting final histological diagnosis for breast lesions of uncertain malignancy (B3 lesions): a systematic review & meta-analysis. Eur J Surg Oncol 48:1464\u20131474","journal-title":"Eur J Surg Oncol"},{"key":"4672_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-025-07834-z","volume":"215","author":"JC Dalton","year":"2025","unstructured":"Dalton JC, Nierenberg TC, Leonard A et al (2025) Risk prediction models for malignancy upgrade in high-risk breast lesions: a qualitative systematic review. Breast Cancer Res Treat 215:3","journal-title":"Breast Cancer Res Treat"},{"key":"4672_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.suronc.2020.04.002","volume":"34","author":"M Cohen","year":"2020","unstructured":"Cohen M, Benhaim S, Coudray AJ et al (2020) When to do surgical resection for atypical breast lesions: results of a prospective cohort of 518 lesions. Surg Oncol 34:80\u201385","journal-title":"Surg Oncol"},{"key":"4672_CR21","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.ejca.2007.06.007","volume":"43","author":"SJ Lord","year":"2007","unstructured":"Lord SJ, Lei W, Craft P et al (2007) A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43:1905\u20131917","journal-title":"Eur J Cancer"},{"key":"4672_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2026.111410","volume":"52","author":"SJE Ermans","year":"2026","unstructured":"Ermans SJE, Maas R, Hill TM et al (2026) Comparison of contrast-enhanced mammography and breast MRI in tumour extent assessment: a systematic review and meta-analysis. Eur J Surg Oncol 52:111410","journal-title":"Eur J Surg Oncol"},{"key":"4672_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-077039","volume":"384","author":"K Freeman","year":"2024","unstructured":"Freeman K, Jenkinson D, Clements K et al (2024) Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in England. BMJ 384:e077039","journal-title":"BMJ"},{"key":"4672_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/bjr\/tqad053","volume":"97","author":"K Freeman","year":"2024","unstructured":"Freeman K, Mansbridge A, Stobart H et al (2024) Evidence-informed recommendations on managing breast screening atypia: perspectives from an expert panel consensus meeting reviewing results from the Sloane atypia project. Br J Radiol 97:324\u2013330","journal-title":"Br J Radiol"},{"key":"#cr-split#-4672_CR25.1","unstructured":"NHS England\u00a0(2010) Clinical guidance for breast cancer screening assessment [Internet]. London: GOV.UK [updated 2026"},{"key":"#cr-split#-4672_CR25.2","unstructured":"cited 2026 May 20]. Available from: https:\/\/www.gov.uk\/government\/publications\/breast-screening-clinical-guidelines-for-screening-management\/clinical-guidance-for-breast-cancer-screening-assessment"},{"key":"4672_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12880-018-0271-7","volume":"18","author":"H Preibsch","year":"2018","unstructured":"Preibsch H, Wanner LK, Staebler A et al (2018) Malignancy rates of B3-lesions in breast magnetic resonance imaging - do all lesions have to be excised? BMC Med Imaging 18:27","journal-title":"BMC Med Imaging"},{"key":"4672_CR27","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1007\/s00268-013-2191-6","volume":"37","author":"GM Maclean","year":"2013","unstructured":"Maclean GM, Courtney SP, Umeh H et al (2013) Is mode of presentation of B3 breast core biopsies (screen-detected or symptomatic) a distinguishing factor in the final histopathologic result or risk of diagnosis of malignancy? World J Surg 37:2607\u20132612","journal-title":"World J Surg"},{"key":"4672_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.clbc.2022.02.004","volume":"22","author":"SE Sheikh","year":"2022","unstructured":"Sheikh SE, Rathbone M, Chaudhary K et al (2022) Rates and Outcomes of Breast Lesions of Uncertain Malignant Potential (B3) benchmarked against the National Breast Screening Pathology Audit; Improving Performance in a High Volume Screening Unit. Clin Breast Cancer 22:381\u2013390","journal-title":"Clin Breast Cancer"},{"key":"4672_CR29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/jama.1992.03480070057030","volume":"267","author":"SJ London","year":"1992","unstructured":"London SJ, Connolly JL, Schnitt SJ et al (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941\u2013944","journal-title":"JAMA"},{"key":"4672_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa044383","volume":"353","author":"LC Hartmann","year":"2005","unstructured":"Hartmann LC, Sellers TA, Frost MH et al (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229\u2013237","journal-title":"N Engl J Med"},{"key":"4672_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13244-021-01005-6","volume":"12","author":"F Catanzariti","year":"2021","unstructured":"Catanzariti F, Avendano D, Cicero G et al (2021) High-risk lesions of the breast: concurrent diagnostic tools and management recommendations. Insights Imaging 12:63","journal-title":"Insights Imaging"},{"key":"4672_CR32","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s00330-020-07161-5","volume":"31","author":"M Lucioni","year":"2021","unstructured":"Lucioni M, Rossi C, Lomoro P et al (2021) Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? Eur Radiol 31:920\u2013927","journal-title":"Eur Radiol"},{"key":"4672_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2303.2008.00610.x","volume":"19","author":"G Kocjan","year":"2008","unstructured":"Kocjan G, Bourgain C, Fassina A et al (2008) The role of breast FNAC in diagnosis and clinical management: a survey of current practice. Cytopathology 19:271\u2013278","journal-title":"Cytopathology"},{"key":"4672_CR34","doi-asserted-by":"crossref","unstructured":"Schilling K, Love N (1995) Screening and diagnostic breast imaging procedures. A look at lesions through a radiologist\u2019s eyes. Postgrad Med 98:44\u2009\u2013\u20096, 51, 56 passim","DOI":"10.1080\/00325481.1995.11946055"},{"key":"4672_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clinimag.2021.06.032","volume":"80","author":"A Starikov","year":"2021","unstructured":"Starikov A, Askin G, Blackburn A et al (2021) Mode of detection matters: Differences in screen-detected versus symptomatic breast cancers. Clin Imaging 80:11\u201315","journal-title":"Clin Imaging"},{"key":"#cr-split#-4672_CR36.1","unstructured":"NHS England\u00a0(2020) The surveillance of women at very high risk of developing breast cancer [Internet]. London: GOV.UK [updated 2025"},{"key":"#cr-split#-4672_CR36.2","unstructured":"cited 2026 May 20]. Available from: https:\/\/www.gov.uk\/government\/publications\/breast-screening-higher-risk-women-surveillance-protocols\/the-surveillance-of-women-at-very-high-risk-of-developing-breast-cancer"},{"key":"#cr-split#-4672_CR37.1","unstructured":"NHS England\u00a0(2020) Eligibility criteria and screening protocols for women at very high risk of breast cancer [Internet]. London: GOV.UK [updated 2025"},{"key":"#cr-split#-4672_CR37.2","unstructured":"cited 2026 May 20]. Available from: https:\/\/www.gov.uk\/government\/publications\/breast-screening-higher-risk-women-surveillance-protocols\/eligibility-criteria-and-screening-protocols-for-women-at-very-high-risk-of-breast-cancer"},{"key":"4672_CR38","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/his.15402","volume":"86","author":"S El Sheikh","year":"2025","unstructured":"El Sheikh S, Mansour MA, Provenzano E et al (2025) Diagnostic interobserver variability of atypia assessment in columnar cell lesions among a group of expert breast pathologists in the United Kingdom and the Republic of Ireland, on behalf of the UK national coordinating committee for breast pathology. Histopathology 86:953\u2013966","journal-title":"Histopathology"},{"key":"4672_CR39","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/jclinpath-2017-204977","volume":"71","author":"BF Dessauvagie","year":"2018","unstructured":"Dessauvagie BF, Lee AHS, Meehan K et al (2018) Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology. J Clin Pathol 71:672\u2013679","journal-title":"J Clin Pathol"},{"key":"4672_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1746-1596-9-121","volume":"9","author":"DS Gomes","year":"2014","unstructured":"Gomes DS, Porto SS, Balabram D et al (2014) Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast. Diagn Pathol 9:121","journal-title":"Diagn Pathol"},{"key":"4672_CR41","doi-asserted-by":"publisher","first-page":"516","DOI":"10.2214\/AJR.07.2206","volume":"190","author":"HJ Shin","year":"2008","unstructured":"Shin HJ, Kim HH, Kim SM et al (2008) Screening-detected and symptomatic ductal carcinoma in situ: differences in the sonographic and pathologic features. AJR Am J Roentgenol 190:516\u2013525","journal-title":"AJR Am J Roentgenol"},{"key":"4672_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ejso.2013.12.013","volume":"40","author":"NL Barnes","year":"2014","unstructured":"Barnes NL, Dimopoulos N, Williams KE et al (2014) The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast. Eur J Surg Oncol 40:249\u2013254","journal-title":"Eur J Surg Oncol"},{"key":"4672_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.clinimag.2020.11.050","volume":"73","author":"SL Venkatesh","year":"2021","unstructured":"Venkatesh SL, Oseni TO, Bahl M (2021) Symptomatic ductal carcinoma in situ (DCIS): Upstaging risk and predictors. Clin Imaging 73:101\u2013107","journal-title":"Clin Imaging"},{"key":"4672_CR44","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10549-011-1836-0","volume":"131","author":"J Kim","year":"2012","unstructured":"Kim J, Lee S, Bae S et al (2012) Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes. Breast Cancer Res Treat 131:527\u2013540","journal-title":"Breast Cancer Res Treat"},{"key":"4672_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.32074\/1591-951X-123","volume":"113","author":"AG Corradini","year":"2021","unstructured":"Corradini AG, Cremonini A, Cattani MG et al (2021) Which type of cancer is detected in breast screening programs? Review of the literature with focus on the most frequent histological features. Pathologica 113:85\u201394","journal-title":"Pathologica"},{"key":"4672_CR46","first-page":"202","volume":"22","author":"SS Lau","year":"2016","unstructured":"Lau SS, Cheung PS, Wong TT et al (2016) Comparison of clinical and pathological characteristics between screen-detected and self-detected breast cancers: a Hong Kong study. Hong Kong Med J 22:202\u2013209","journal-title":"Hong Kong Med J"},{"key":"4672_CR47","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s12282-018-00943-2","volume":"26","author":"CJ Rageth","year":"2019","unstructured":"Rageth CJ, Rubenov R, Bronz C et al (2019) Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens. Breast Cancer 26:452\u2013458","journal-title":"Breast Cancer"},{"key":"4672_CR48","doi-asserted-by":"publisher","first-page":"103807","DOI":"10.1016\/j.breast.2024.103807","volume":"78","author":"J Baker","year":"2024","unstructured":"Baker J, Noguchi N, Marinovich ML et al (2024) Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysis. Breast 78:103807","journal-title":"Breast"},{"key":"4672_CR49","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1245\/s10434-017-6059-0","volume":"24","author":"AV Rudin","year":"2017","unstructured":"Rudin AV, Hoskin TL, Fahy A et al (2017) Flat Epithelial Atypia on Core Biopsy and Upgrade to Cancer: a Systematic Review and Meta-Analysis. Ann Surg Oncol 24:3549\u20133558","journal-title":"Ann Surg Oncol"},{"key":"4672_CR50","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1245\/s10434-024-16762-z","volume":"32","author":"F Nakhlis","year":"2025","unstructured":"Nakhlis F, Baker GM, Li T et al (2025) Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and\/or Ductal Carcinoma In Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy (TBCRC 034). Ann Surg Oncol 32:2578\u20132584","journal-title":"Ann Surg Oncol"},{"key":"4672_CR51","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/SLA.0b013e318233523f","volume":"255","author":"AH Verschuur-Maes","year":"2012","unstructured":"Verschuur-Maes AH, van Deurzen CH, Monninkhof EM et al (2012) Columnar cell lesions on breast needle biopsies: is surgical excision necessary? A systematic review. Ann Surg 255:259\u2013265","journal-title":"Ann Surg"},{"key":"4672_CR52","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1245\/s10434-020-09107-z","volume":"28","author":"C Uzan","year":"2021","unstructured":"Uzan C, Mazouni C, Rossoni C et al (2021) Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions. Ann Surg Oncol 28:2138\u20132145","journal-title":"Ann Surg Oncol"},{"key":"4672_CR53","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1148\/radiol.2016151947","volume":"281","author":"C Verheyden","year":"2016","unstructured":"Verheyden C, Pages-Bouic E, Balleyguier C et al (2016) Underestimation Rate at MR Imaging-guided Vacuum-assisted Breast Biopsy: A Multi-Institutional Retrospective Study of 1509 Breast Biopsies. Radiology 281:708\u2013719","journal-title":"Radiology"},{"key":"4672_CR54","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20180300","volume":"91","author":"ME Speer","year":"2018","unstructured":"Speer ME, Huang ML, Dogan BE et al (2018) High risk breast lesions identified on MRI-guided vacuum-assisted needle biopsy: outcome of surgical excision and imaging follow-up. Br J Radiol 91:20180300","journal-title":"Br J Radiol"},{"key":"4672_CR55","doi-asserted-by":"publisher","first-page":"e643","DOI":"10.1016\/j.clbc.2019.06.004","volume":"19","author":"D Santucci","year":"2019","unstructured":"Santucci D, Faiella E, Calabrese A et al (2019) Our Radiological Experience on B3 Lesions: Correlation Between Mammographic and MRI Findings With Histologic Definitive Result. Clin Breast Cancer 19:e643\u2013e653","journal-title":"Clin Breast Cancer"},{"key":"4672_CR56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/his.70017","volume":"88","author":"A Llewellyn","year":"2026","unstructured":"Llewellyn A, Brown A, Morel J et al (2026) To VAE or not to VAE: outcomes of radial scars\/complex sclerosing lesions and papillary lesions without atypia in the King\u2019s College Hospital breast service (2017\u20132023). Histopathology 88:583\u2013590","journal-title":"Histopathology"},{"key":"4672_CR57","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12282-019-01032-8","volume":"27","author":"S Okamoto","year":"2020","unstructured":"Okamoto S, Chen ST, Covelli JD et al (2020) High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up. Breast Cancer 27:405\u2013414","journal-title":"Breast Cancer"},{"key":"4672_CR58","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJMsr1407164","volume":"372","author":"LC Hartmann","year":"2015","unstructured":"Hartmann LC, Degnim AC, Santen RJ et al (2015) Atypical hyperplasia of the breast\u2013risk assessment and management options. N Engl J Med 372:78\u201389","journal-title":"N Engl J Med"},{"key":"4672_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pathol.2015.11.015","volume":"48","author":"AA Renshaw","year":"2016","unstructured":"Renshaw AA, Gould EW (2016) Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Pathology 48:25\u201329","journal-title":"Pathology"},{"key":"4672_CR60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/jamasurg.2023.6382","volume":"159","author":"ME Sherman","year":"2024","unstructured":"Sherman ME, Vierkant RA, Winham SJ et al (2024) Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era. JAMA Surg 159:193\u2013201","journal-title":"JAMA Surg"},{"key":"4672_CR61","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10549-014-3254-6","volume":"149","author":"SW Dyrstad","year":"2015","unstructured":"Dyrstad SW, Yan Y, Fowler AM et al (2015) Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res Treat 149:569\u2013575","journal-title":"Breast Cancer Res Treat"},{"key":"4672_CR62","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1245\/s10434-015-4747-1","volume":"22","author":"MP McEvoy","year":"2015","unstructured":"McEvoy MP, Coopey SB, Mazzola E et al (2015) Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS). Ann Surg Oncol 22:3346\u20133349","journal-title":"Ann Surg Oncol"},{"key":"4672_CR63","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jss.2019.03.047","volume":"241","author":"AR Sergesketter","year":"2019","unstructured":"Sergesketter AR, Thomas SM, Fayanju OM et al (2019) The Influence of Age on the Histopathology and Prognosis of Atypical Breast Lesions. J Surg Res 241:188\u2013198","journal-title":"J Surg Res"},{"key":"4672_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2025.116598","volume":"250","author":"TC Nierenberg","year":"2025","unstructured":"Nierenberg TC, Dalton JC, Howell R et al (2025) Risk assessment tools for women with breast atypia: a systematic review. Am J Surg 250:116598","journal-title":"Am J Surg"},{"key":"4672_CR65","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.mpdhp.2024.12.002","volume":"31","author":"AM Shaaban","year":"2025","unstructured":"Shaaban AM, McMahon MA, Sharma N (2025) Recent advances in the diagnosis and management of B3 lesions. Diagn Histopathology 31:145\u2013151","journal-title":"Diagn Histopathology"},{"key":"4672_CR66","unstructured":"Gradishar WJ, Moran MS, Abraham J et al (2026) NCCN clinical practice guidelines in oncology. Breast Cancer v1. (Downloaded from NCCN.org on 08 Feb 2026)"},{"key":"4672_CR67","volume-title":"Breast Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2026","unstructured":"WHO Classification of Tumours Editorial Board (2026) Breast Tumours, Beta version; 6th edition. International Agency for Research on Cancer, Lyon (France)","edition":"Beta version; 6"},{"key":"4672_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1394116","volume":"14","author":"M Gil","year":"2024","unstructured":"Gil M, Coelho BA, Couto HL et al (2024) Vacuum-assisted excision: a safe minimally invasive option for benign phyllodes tumor diagnosis and treatment-a systematic review and meta-analysis. Front Oncol 14:1394116","journal-title":"Front Oncol"},{"key":"4672_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/jcp-2026-210821","author":"EA Rakha","year":"2026","unstructured":"Rakha EA (2026) Contextual interpretation of luminal phenotype in low-grade breast epithelial proliferations. J Clin Pathol. https:\/\/doi.org\/10.1136\/jcp-2026-210821","journal-title":"J Clin Pathol"},{"key":"4672_CR70","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/his.70072","volume":"88","author":"EA Rakha","year":"2026","unstructured":"Rakha EA, Tan PH, Raymond WA (2026) The spectrum of breast in situ papillary carcinomas with invasion and invasive breast carcinomas with papillary features: an overview of histological subtypes and diagnostic challenges. Histopathology 88:747\u2013768","journal-title":"Histopathology"},{"key":"4672_CR71","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/tbj.12929","volume":"24","author":"G Zhang","year":"2018","unstructured":"Zhang G, Ataya D (2018) Mucocele-like lesions diagnosed on breast core biopsy: Low risk of upgrade and subsequent carcinoma. Breast J 24:314\u2013318","journal-title":"Breast J"},{"key":"4672_CR72","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/his.12081","volume":"62","author":"EA Rakha","year":"2013","unstructured":"Rakha EA, Shaaban AM, Haider SA et al (2013) Outcome of pure mucocele-like lesions diagnosed on breast core biopsy. Histopathology 62:894\u2013898","journal-title":"Histopathology"},{"key":"4672_CR73","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/jbi\/wbae006","volume":"6","author":"A Chandora","year":"2024","unstructured":"Chandora A, Kahn AG, Zamora K (2024) Mucocele-like Lesions: Radiologic-Pathologic Correlation. J Breast Imaging 6:175\u2013182","journal-title":"J Breast Imaging"},{"key":"4672_CR74","first-page":"16","volume":"6","author":"MJ Plaza","year":"2012","unstructured":"Plaza MJ, Yepes M (2012) Breast fibromatosis response to tamoxifen: dynamic MRI findings and review of the current treatment options. J Radiol Case Rep 6:16\u201323","journal-title":"J Radiol Case Rep"},{"key":"4672_CR75","first-page":"79","volume":"14","author":"DE Lacka","year":"2019","unstructured":"Lacka DE, Nasierowska-Guttmejer A (2019) Fibromatosis - immunohistochemical evaluation, differential diagnosis from gastrointestinal tumors, and other mesenchymal tumours. Prz Gastroenterol 14:79\u201385","journal-title":"Prz Gastroenterol"},{"key":"4672_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020273","author":"YS Lee","year":"2024","unstructured":"Lee YS, Joo MW, Shin SH et al (2024) Current treatment concepts for extra-abdominal desmoid-type fibromatosis: a narrative review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16020273","journal-title":"Cancers (Basel)"},{"key":"4672_CR77","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejca.2019.11.013","volume":"127","author":"Desmoid Tumor Working G","year":"2020","unstructured":"Desmoid Tumor Working G (2020) The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer 127:96\u2013107","journal-title":"Eur J Cancer"},{"key":"4672_CR78","doi-asserted-by":"publisher","first-page":"815","DOI":"10.6004\/jnccn.2022.0035","volume":"20","author":"M von Mehren","year":"2022","unstructured":"von Mehren M, Kane JM, Agulnik M et al (2022) Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20:815\u2013833","journal-title":"J Natl Compr Canc Netw"},{"key":"4672_CR79","doi-asserted-by":"publisher","first-page":"5803290","DOI":"10.1155\/2024\/5803290","volume":"2024","author":"M Wu","year":"2024","unstructured":"Wu M, Hughes TM, Edirimanne S et al (2024) Breast Desmoid Tumours: A Review of the Literature. Breast J 2024:5803290","journal-title":"Breast J"},{"key":"4672_CR80","doi-asserted-by":"publisher","first-page":"394","DOI":"10.14740\/wjon1844","volume":"15","author":"A Kangas-Dick","year":"2024","unstructured":"Kangas-Dick A, Ali M, Poss M et al (2024) Diagnosis and Management of Desmoid Fibromatosis of the Breast. World J Oncol 15:394\u2013404","journal-title":"World J Oncol"},{"key":"4672_CR81","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/modpathol.2012.83","volume":"25","author":"EG Demicco","year":"2012","unstructured":"Demicco EG, Park MS, Araujo DM et al (2012) Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol 25:1298\u20131306","journal-title":"Mod Pathol"},{"key":"4672_CR82","unstructured":"The American Society of Breast Surgeons (ASBrS) (2025) Resource Guide: Surgical Management of Benign or High-Risk Breast Lesions. https:\/\/www.breastsurgeons.org\/docs\/statements\/asbrs-high-risk-lesions.pdf"},{"key":"4672_CR83","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10549-022-06577-5","volume":"193","author":"B Bychkovsky","year":"2022","unstructured":"Bychkovsky B, Laws A, Katlin F et al (2022) Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen. Breast Cancer Res Treat 193:417\u2013427","journal-title":"Breast Cancer Res Treat"},{"key":"4672_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2026.112825","volume":"200","author":"P Widmayer","year":"2026","unstructured":"Widmayer P, Ferrari-Kanzler E, Haider SP et al (2026) A systematic comparison of abbreviated and unenhanced breast MRI protocols in women with mammographically dense breasts compared to full multiparametric breast MR imaging. Eur J Radiol 200:112825","journal-title":"Eur J Radiol"},{"key":"4672_CR85","doi-asserted-by":"crossref","unstructured":"D\u2019Archi S, Carnassale B, Sanchez AM et al (2025) Navigating the uncertainty of B3 breast lesions: diagnostic challenges and evolving management strategies. J Pers Med 15","DOI":"10.3390\/jpm15010036"},{"key":"4672_CR86","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1245\/s10434-020-09426-1","volume":"28","author":"TM Allweis","year":"2021","unstructured":"Allweis TM, Hermann N, Berenstein-Molho R et al (2021) Personalized Screening for Breast Cancer: Rationale, Present Practices, and Future Directions. Ann Surg Oncol 28:4306\u20134317","journal-title":"Ann Surg Oncol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04672-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04672-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04672-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:02:12Z","timestamp":1793084532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04672-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4672"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04672-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"19 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study does not involve human participants.","order":1,"name":"Ethics","label":"Research ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not involve human participants.","order":2,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares the use of generative artificial intelligence tools (ChatGPT and Gemini) to assist in manuscript preparation, specifically for language refinement and structural editing. All scientific content, interpretations, and conclusions were independently developed, critically reviewed, and approved by the authors.","order":3,"name":"Ethics","label":"Declaration of generative AI use","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No relevant COI to declare","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}